Name: Regulation, Innovation and Competition in Pharmaceutical Markets: A Comparative Study (en Inglés)
Price: 282406.00 COP
Availability: InStock
Author: Colangelo, Margherita ; Hervey, Tamara ; Murphy, Thérèse
ISBN: 9781509965557

portada Regulation, Innovation and Competition in Pharmaceutical Markets: A Comparative Study (en Inglés)

Regulation, Innovation and Competition in Pharmaceutical Markets: A Comparative Study (en Inglés)

Formato

Libro Físico

Autor

Ilustrado por

Editorial

Idioma

Inglés

N° páginas

256

Encuadernación

Tapa Blanda

Dimensiones

23.4 x 15.6 x 2.5 cm

Peso

0.45 kg.

ISBN13

9781509965557

Categorías

Derecho comparado
Derecho de la competencia y competencia desleal. legislación antimonopolios
Derecho médico y sanitario

Regulation, Innovation and Competition in Pharmaceutical Markets: A Comparative Study (en Inglés)

Margherita Colangelo (Autor) · Thérèse Murphy (Ilustrado por) · Tamara Hervey (Ilustrado por) · Hart Publishing · Tapa Blanda

Libro Nuevo Importado

Envío: 18 a 24 días háb.

$ 564.813$ 282.406

-50%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan 50 unidades

$ 282.406

¡Envío Gratis! Llega entre el 17 Jul y el 29 Jul a Bogota, Cundinamarca. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Regulation, Innovation and Competition in Pharmaceutical Markets: A Comparative Study (en Inglés)"

This book explores the fundamental and inextricable relationship between regulation, intellectual property, competition law, and public health in pharmaceutical markets, examining their interconnections and the delicate balance between the various interests and policy goals at stake. Although pharmaceutical markets are heavily regulated and subject to close antitrust scrutiny, there is a constant requirement for existing rules and policies to tackle a number of persistent, complex issues. The variety of anti-competitive practices occurring in this sector, the worrying rise in drug prices, and major, far-reaching concerns over the accessibility of medicines are sources of frequent controversy in academic and policy debates. Understanding the unique features and dynamics of the pharmaceutical industry requires a tailored and multifaceted approach. The study is enhanced by the adoption of a comparative perspective, tracing convergence and divergence between EU and US systems through the analysis of relevant applicable rules, significant cases, and policy choices. Pursuant to this rigorous approach, the book provides an original and thought-provoking critique of the challenges of regulating pharmaceutical markets.